How appetite is controlled

Current Opinion in Endocrinology and Diabetes

Volumn 9, Issue 2, 2002, Pages 145-151

  Wren, Alison Margaret ^a   Bloom, Stephen Robert ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AGOUTI RELATED PROTEIN; CANNABINOID; GHRELIN; GLUCAGON LIKE PEPTIDE; LEPTIN; MELANIN CONCENTRATING HORMONE; MELANOCORTIN; NEUROPEPTIDE; NEUROPEPTIDE Y;

APPETITE; BODY MASS; BODY WEIGHT; CACHEXIA; CALORIC INTAKE; ENERGY EXPENDITURE; FEEDBACK SYSTEM; FOOD INTAKE; HUMAN; OBESITY; REVIEW; SATIETY;

EID: 0036308460     PISSN: 10683097     EISSN: None     Source Type: Journal    
DOI: 10.1097/00060793-200204000-00004     Document Type: Review

References (91)

1. Energy balance in man studies carried out by the Division of Human Physiology, National Institute for Medical Research
2. The role of depot fat in the hypothalamic control of food intake in the rat
3. Serum immunoreactive-leptin concentrations in normal-weight and obese humans
4. The significance of basal insulin levels in the evaluation of the insulin response to glucose in diabetic and nondiabetic subjects
5. Effect of fasting, refeeding, and dietary fat restriction on plasma leptin levels
6. Effect of fasting on serum leptin in normal human subjects
7. Recombinant mouse OB protein: Evidence for a peripheral signal linking adiposity and central neural networks
8. Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons
9. Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus
10. Proopiomelanocortin neurons are direct targets for leptin in the hypothalamus
11. Insulin and insulin-like growth factors in the CNS
12. Positional cloning of the mouse obese gene and its human homologue
13. Congenital leptin deficiency is associated with severe early-onset obesity in humans
14. Effect of intracerebroventricular insulin infusion on diabetic hyperphagia and hypothalamic neuropeptide gene expression
15. Evidence that glucose metabolism regulates leptin secretion from cultured rat adipocytes
16. Low plasma leptin levels contribute to diabetic hyperphagia in rats
17. Cerebrospinal fluid leptin levels: Relationship to plasma levels and to adiposity in humans
18. Phenotypes of mouse diabetes and rat fatty due to mutations in the OB (leptin) receptor
19. Expression of leptin receptor isoforms in rat brain microvessels
20. Identification of SOCS-3 as a potential mediator of central leptin resistance
21. Fatty acid oxidation affects food intake by altering hepatic energy status
22. Induction of Fos-like immunoreactivity (Fos-li) and stimulation of feeding by 2,5-anhydro-D-mannitol (2,5-AM) require the vagus nerve
23. Cholecystokinin and satiety: Current perspectives
24. Gustatory neural processing in the hindbrain
25. Ascending projections from the solitary tract nucleus to the hypothalamus: A Phaseolus vulgaris lectin tracing study in the rat
26. Central leptin modulates behavioral and neural responsivity to CCK
27. Ghrelin is a growth-hormone-releasing acylated peptide from stomach
28. Ghrelin induces adiposity in rodents
29. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion
30. Ghrelin is an appetite-stimulatory signal from stomach with structural resemblance to motilin
31. A role for ghrelin in the central regulation of feeding
32. Ghrelin enhances appetite and increases food intake in humans
33. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans
34. Ghrelin causes hyperphagia and obesity in rats
35. Circulating ghrelin levels are decreased in human obesity
36. Plasma ghrelin concentration and energy balance: Overfeeding and negative energy balance studies in twins
37. Stomach is a major source of circulating ghrelin, and feeding state determines plasma ghrelin-like immunoreactivity levels in humans
38. Physiological and anatomical circuitry between agouti-related protein and leptin signaling
39. Specificity of leptin action on elevated blood glucose levels and hypothalamic neuropeptide Y gene expression in ob/ob mice
40. Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting
41. Systemic administration of ghrelin induces Fos and Egr-1 proteins in the hypothalamic arcuate nucleus of fasted and fed rats
42. Central effect of ghrelin, an endogenous growth hormone secretagogue, on hypothalamic peptide gene expression
43. Central nervous system control of food intake
44. Interacting appetite-regulating pathways in the hypothalamic regulation of body weight
45. The neuropeptide Y/agouti gene-related protein (AGRP) brain circuitry in normal, anorectic, and monosodium glutamate-treated mice
46. Leptin activates hypothalamic CART neurons projecting to the spinal cord
47. Identification of targets of leptin action in rat hypothalamus
48. Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain
49. Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein
50. Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice
51. A C-terminal fragment of agouti-related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo
52. Effects of chronic central nervous system administration of agouti-related protein in pair-fed animals
53. Cloning of the mouse agouti gene predicts a secreted protein ubiquitously expressed in mice carrying the lethal yellow mutation
54. Targeted disruption of the melanocortin-4 receptor results in obesity in mice
55. Obesity in the mouse model of proopiomelanocortin deficiency responds to peripheral melanocortin
56. Transgenic expression of syndecan-1 uncovers a physiological control of feeding behavior by syndecan-3
57. Inactivation of the mouse melanocortin-3 receptor results in increased fat mass and reduced lean body mass
58. A metabolic defect promotes obesity in mice lacking melanocortin-4 receptors
59. The central melanocortin system affects the hypothalamo-pituitary thyroid axis and may mediate the effect of leptin
60. Integrated control of appetite and fat metabolism by the leptin-proopiomelanocortin pathway
61. Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans
62. Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene
63. The role of melanocortin signalling in the control of body weight: Evidence from human and murine genetic models
64. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity
65. Association between and agouti-related protein gene polymorphism and anorexia nervosa
66. The melanocortin melanocyte-stimulating hormone/adrenocorticotropin(4-10) decreases body fat in humans
67. Neuropeptide Y injected in the paraventricular hypothalamus: A powerful stimulant of feeding behavior
68. Neuropeptide Y chronically injected into the hypothalamus: A powerful neurochemical inducer of hyperphagia and obesity
69. Increased hypothalamic content of preproneuropeptide Y messenger ribonucleic acid in genetically obese Zucker rats and its regulation by food deprivation
70. Sensitivity to leptin and susceptibility to seizures of mice lacking neuropeptide Y
71. Attenuation of the obesity syndrome of ob/ob mice by the loss of neuropeptide Y
72. Normal feeding behavior, body weight and leptin response require the neuropeptide Y Y2 receptor
73. Activation of the NPY Y5 receptor regulates both feeding and energy expenditure
74. Neuropeptide Y has a central inhibitory action on the hypothalamic-pituitary-thyroid axis
75. Hypothalamic CART is a new anorectic peptide regulated by leptin
76. CART peptides in the central control of feeding and interactions with neuropeptide Y
77. Evidence of an orexigenic role for cocaine- and amphetamine regulated transcript after administration into discrete hypothalamic nuclei
78. A role for melanin-concentrating hormone in the central regulation of feeding behaviour
79. Melanin-concentrating hormone acutely stimulates feeding, but chronic administration has no effect on body weight
80. Mice lacking melanin-concentrating hormone are hypophagic and lean
81. Melanin-concentratin9 hormone overexpression in transgenic mice leads to obesity and insulin resistance
82. Melanin-concentrating hormone (MCH) suppresses thyroid stimulating hormone (TSH) release, in vivo and in vitro, via the hypothalamus and the pituitary
83. Anandamide induces overeating: Mediation by central cannabinoid (CB1) receptors
84. Appetite suppression and weight loss after the cannabinoid antagonist SR 141716
85. Leptin-regulated endocannabinoids are involved in maintaining food intake
86. A role for glucagon-like peptide-1 in the central regulation of feeding
87. The proglucagon-derived peptide, glucagon-like peptide-2, is a neurotransmitter involved in the regulation of food intake
88. Oxyntomodulin inhibits food intake in the rat
89. Exendin-4 reduces fasting and post-prandial glucose and decreases energy intake in healthy volunteers
90. Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene